The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 334:391-392 February 8, 1996 Number 6
NextNext

Acellular Pertussis Vaccines for Infants

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Whole-cell vaccines, which are suspensions of killed Bordetella pertussis organisms, are among our most effective and least satisfactory vaccines. Before immunization was routine, pertussis was endemic in the United States, with up to 260,000 cases and 9000 deaths per year.1 By 1976 there were only 1010 cases and 7 deaths.1 Although the whole-cell vaccines have been effective, adverse effects are common. Worse still, pertussis vaccine has been temporally associated with devastating events such as sudden infant death. Although most careful studies suggest no causal relation, the existing pertussis vaccines have remained a source of disquiet to physicians and parents alike.

. . . [Full Text of this Article]

References


Related Letters:

Acellular Pertussis Vaccines
Poltera A. A., Tamburlini G., Materassi P., Decker M. D., Edwards K. M.
Extract | Full Text  
N Engl J Med 1996; 334:1547-1548, Jun 6, 1996. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.